We previously showed that increased IL-1β responses drive steroid-insensitive, inflammation and AHR, and that inhibiting NLRP3 activation with MCC950 reduced IL-1β production and ablated these features in murine models of severe asthma [27]. The gene discussed is NLRP3; the disease is asthma.